Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas
1998

Prognostic Significance of Bax Expression and AgNOR Counts in Glottic Carcinomas

Sample size: 69 publication Evidence: high

Author Information

Author(s): X Xie, OPF Clausen, P De Angelis, M Boysen

Primary Institution: The National Hospital, Rikshospitalet, University of Oslo

Hypothesis

The study investigates the prognostic significance of Bax expression and AgNOR counts in glottic squamous cell carcinomas.

Conclusion

Both Bax expression and AgNOR scores, especially their combination, are strong prognostic markers in glottic squamous cell carcinomas.

Supporting Evidence

  • Low Bax scores correlated significantly with poor prognosis (P = 0.0106).
  • High mAgNOR and pAgNOR>1 values correlated with poor prognosis (P= 0.0185 and P = 0.0003 respectively).
  • The combination of Bax and AgNOR scores was a statistically stronger prognostic factor than the individual parameters (P < 0.0001).

Takeaway

This study found that certain markers in cancer cells can help predict how well patients will do after treatment.

Methodology

The study involved staining tissue samples from 69 patients with glottic carcinomas to evaluate Bax expression and AgNOR counts.

Limitations

The study's findings may not be generalizable due to the specific patient population and treatment methods used.

Participant Demographics

The mean age of participants was 62 years, with 2 females and 67 males.

Statistical Information

P-Value

0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication